BIOTENE MOISTURIZING MOUTH SPRAY (2013 FORMULATION)

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-04-01 for BIOTENE MOISTURIZING MOUTH SPRAY (2013 FORMULATION) manufactured by Ultradent Products Inc/oratech Llc.

Event Text Entries

[140815821] Mfr report is associated with argus case (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[140815822] Tightness in the patient? S throat [throat tightness], tingling in the patient? S throat [pharyngeal paresthesia], building choking feeling [choking sensation], anaphylactic shock [anaphylactic shock]. Case description: this case was reported by a consumer via call center representative and described the occurrence of throat tightness in a patient who received glycerin (biotene moisturizing mouth spray (2013 formulation)) oromucosal spray for drug use for unknown indication. Concurrent medical conditions included sulfonamide allergy. On an unknown date, the patient started biotene moisturizing mouth spray (2013 formulation). On an unknown date, an unknown time after starting biotene moisturizing mouth spray (2013 formulation), the patient experienced throat tightness, tingling throat and choking sensation. The action taken with biotene moisturizing mouth spray (2013 formulation) was unknown. On an unknown date, the outcome of the throat tightness, tingling throat and choking sensation were unknown. It was unknown if the reporter considered the throat tightness, tingling throat and choking sensation to be related to biotene moisturizing mouth spray (2013 formulation). Additional details: the reporter said it should not be used by anyone with allergy to sulfa drugs. It could downright deadly depending upon sensitivity of patient. The patient reported tightness and tingling in throat, a building choking sensation. The side effect came on third spray of day and started to have serious issue. Follow up information was received on 07 mar 2019: lot code was (batch number u8g131). The patient experienced anaphylactic shock (serious criteria gsk medically significant). The action taken with biotene moisturizing mouth spray (2013 formulation) was unknown. On an unknown date, the outcome of the anaphylactic shock was unknown. It was unknown if the reporter considered the anaphylactic shock to be related to biotene moisturizing mouth spray (2013 formulation). Reason for use dry mouth started. The patient swa health care professional regarding experience. The patient was taken to emergency room for anaphylactic shock.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3012293198-2019-00039
MDR Report Key8469241
Date Received2019-04-01
Date of Report2019-03-06
Date Mfgr Received2019-05-23
Date Added to Maude2019-04-01
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional0
Initial Report to FDA0
Report to FDA3
Event Location3
Manufacturer StreetPO BOX 13398
Manufacturer CityRESEARCH TRIANGLE PARK NC 27709
Manufacturer CountryUS
Manufacturer Postal27709
Manufacturer Phone8888255249
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameBIOTENE MOISTURIZING MOUTH SPRAY (2013 FORMULATION)
Generic NameORAL SPRAY
Product CodeLFD
Date Received2019-04-01
Lot NumberU8G131
OperatorLAY USER/PATIENT
Device Availability*
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerULTRADENT PRODUCTS INC/ORATECH LLC
Manufacturer AddressSOUTH JORDAN UT US


Patients

Patient NumberTreatmentOutcomeDate
101. Other 2019-04-01

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.